back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-08 18:09 Tx date 2026-06-04 |
$SKNY
Lir Life Sciences Corp. |
Nijjar, Harpreet
5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+50,000 vol |
50,000 | |
| Filed 2026-06-08 18:09 Tx date 2025-11-04 |
$SKNY
Lir Life Sciences Corp. |
Nijjar, Harpreet
5 - Senior Officer of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-08 17:54 Tx date 2026-06-04 |
$SKNY
Lir Life Sciences Corp. |
Dybul, Mark
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+50,000 vol |
50,000 | |
| Filed 2026-06-08 17:53 Tx date 2026-06-04 |
$SKNY
Lir Life Sciences Corp. |
May, Kevin Mitchell
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+50,000 vol |
50,000 | |
| Filed 2026-06-08 17:52 Tx date 2026-06-04 |
$SKNY
Lir Life Sciences Corp. |
Carmichel, Constantine
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+50,000 vol |
300,000 | |
| Filed 2026-06-08 17:49 Tx date 2026-06-04 |
$SKNY
Lir Life Sciences Corp. |
Mills, Edward
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: MACREVIEWS HEALTH CONSULTING INCORPORATED (Indirect Ownership)
|
Rights
56 - Grant of rights
|
+300,000 vol |
300,000 | |
| Filed 2026-06-08 17:49 Tx date 2025-11-04 |
$SKNY
Lir Life Sciences Corp. |
Mills, Edward
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: MACREVIEWS HEALTH CONSULTING INCORPORATED (Indirect Ownership)
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-04-20 15:39 Tx date 2026-04-17 |
$SKNY
Lir Life Sciences Corp. |
Nijjar, Harpreet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+100,000 vol |
100,000 | |
| Filed 2026-04-20 15:38 Tx date 2025-11-04 |
$SKNY
Lir Life Sciences Corp. |
Nijjar, Harpreet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-04-20 15:21 Tx date 2026-04-18 |
$SKNY
Lir Life Sciences Corp. |
Dybul, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+100,000 vol |
100,000 | |
| Filed 2026-04-20 15:20 Tx date 2026-04-18 |
$SKNY
Lir Life Sciences Corp. |
Dybul, Mark
4 - Director of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-100,000 vol |
0 | |
| Filed 2026-04-20 15:16 Tx date 2026-04-18 |
$SKNY
Lir Life Sciences Corp. |
May, Kevin Mitchell
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+100,000 vol |
100,000 | |
| Filed 2026-04-20 15:16 Tx date 2026-04-18 |
$SKNY
Lir Life Sciences Corp. |
May, Kevin Mitchell
4 - Director of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-100,000 vol |
0 | |
| Filed 2025-12-29 17:50 Tx date 2025-12-18 |
$SKNY
Lir Life Sciences Corp. |
Carmichel, Constantine
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+250,000 vol |
250,000 | |
| Filed 2025-12-29 17:49 Tx date 2025-11-04 |
$SKNY
Lir Life Sciences Corp. |
Carmichel, Constantine
4 - Director of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-12-23 16:48 Tx date 2025-12-18 |
$SKNY
Lir Life Sciences Corp. |
Dybul, Mark
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+100,000 vol |
100,000 | |
| Filed 2025-12-23 16:47 Tx date 2025-11-04 |
$SKNY
Lir Life Sciences Corp. |
Dybul, Mark
4 - Director of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-12-23 16:00 Tx date 2025-12-18 |
$SKNY
Lir Life Sciences Corp. |
May, Kevin Mitchell
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+100,000 vol |
100,000 | |
| Filed 2025-12-23 15:59 Tx date 2025-11-04 |
$SKNY
Lir Life Sciences Corp. |
May, Kevin Mitchell
4 - Director of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-12-16 15:14 Tx date 2025-12-15 |
$SKNY
Lir Life Sciences Corp. |
Mills, Edward
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,800
+10,000 vol $1.58 each |
155,600 |